Allspring Global Investments
NKTR icon

Allspring Global Investments’s Nektar Therapeutics NKTR Stock Holding History

Allspring Global Investments’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$209K Buy
+2,898
New +$165K ﹤0.01% 1600
2023
Q1 		– Sell
-12,591
Closed -$427K – 2883
2022
Q4 		$427K Buy
12,591
+3,752
+42% +$182K ﹤0.01% 1641
2022
Q3 		$424K Sell
8,839
-615
-7% -$36.6K ﹤0.01% 1621
2022
Q2 		$538K Buy
9,454
+720
+8% +$45.4K ﹤0.01% 1563
2022
Q1 		$706K Buy
8,734
+5,365
+159% +$794K ﹤0.01% 2065
2021
Q4 		$682K Buy
+3,369
New +$731K ﹤0.01% 2156

Other funds holding NKTR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Allspring Global Investments's NKTR Position: Q1 2026 in Review

Allspring Global Investments opened a new position in Nektar Therapeutics (NKTR) in Q1 2026: 2,898 shares worth $209K. The stake represents ﹤0.01% of the portfolio and ranks #1600 among its holdings. This is a return to the name: Allspring Global Investments previously reported a position in NKTR as recently as Q4 2022.

Allspring Global Investments first reported a position in NKTR in Q4 2021 and has held it in 6 quarters since. The position peaked at $706K in Q1 2022. 215 funds tracked by Wall St. Rank hold NKTR as of Q1 2026.

  • Allspring Global Investments held 2,898 shares of Nektar Therapeutics worth $209K as of Q1 2026.
  • Nektar Therapeutics was a new Allspring Global Investments position in Q1 2026.
  • Nektar Therapeutics made up ﹤0.01% of Allspring Global Investments's portfolio in Q1 2026, its #1600 holding.
  • Allspring Global Investments first reported a position in Nektar Therapeutics in Q4 2021 and has held it in 6 quarters since.
  • Allspring Global Investments's Nektar Therapeutics position peaked at $706K in Q1 2022.
  • 215 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q1 2026.

Based on Allspring Global Investments's 13F filing for Q1 2026, filed 5 May 2026.